Multidisciplinary Care for Melanoma of Unknown Primary: Experience in the Era of Molecular Profiling.

Multigene panel testing identified pathogenic mutations in all tested MUP patients and frequently identified targets outside BRAF. Despite advanced stage, aggressive multimodal therapy for MUP can be associated with 5-year OS and should be pursued for appropriate candidates.